Previous Close | 152.92 |
Open | 152.78 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1000 |
Day's Range | 147.35 - 154.58 |
52 Week Range | 56.54 - 286.19 |
Volume | 546,068 |
Avg. Volume | 619,415 |
Market Cap | 4.3B |
Beta (5Y Monthly) | 1.74 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.58 |
Earnings Date | May 05, 2021 - May 10, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 216.83 |
CEDARHURST, N.Y., March 02, 2021 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. SolarWinds Corporation (SWI) Class Period: October 18, 2018 and December 17, 2020Lead Plaintiff Motion Deadline: March 5, 2021SECURITIES FRAUD To learn more, visit https://kclasslaw.com/cases/securities/nyse-swi/ QuantumScape Corporation (QS) Class Period: November 27, 2020 and December 31, 2020Lead Plaintiff Motion Deadline: March 8, 2021SECURITIES FRAUD To learn more, visit https://kclasslaw.com/cases/securities/nyse-qs/ Penumbra, Inc. (PEN) Class Period: August 3, 2020 and December 15, 2020Lead Plaintiff Motion Deadline: March 16, 2021SECURITIES FRAUD To learn more, visit https://kclasslaw.com/cases/securities/nyse-pen/ iRhythm Technologies (IRTC) Class Period: August 4, 2020 and January 28, 2021Lead Plaintiff Motion Deadline: April 2, 2021SECURITIES FRAUD To learn more, visit https://kclasslaw.com/cases/securities/nasdaqgs-irtc/ Shareholders who purchased shares in these companies during the dates listed are encouraged to contact us via the case links above, by calling toll-free at 1-833-835-1495 or by email (dk@kclasslaw.com). If you wish to serve as lead plaintiff with the goal of overseeing the litigation to obtain a fair and just resolution, you must petition the Court on or before the deadlines provided above. Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:Kuznicki Law PLLCDaniel Kuznicki, Esq.445 Central Avenue, Suite 344Cedarhurst, NY 11516Email: dk@kclasslaw.comPhone: (347) 696-1134Cell: (347) 690-0692Fax: (347) 348-0967https://kclasslaw.com
New York, New York--(Newsfile Corp. - March 2, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of iRhythm Technologies, Inc. ("iRhythm") (NASDAQ: IRTC) between August 4, 2020 and January 28, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California. To get more ...
RADNOR, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against iRhythm on behalf of those who purchased or acquired iRhythm common stock between August 4, 2020 and January 28, 2021, inclusive (the “Class Period”). Lead Plaintiff Deadline: April 2, 2021 Website:https://www.ktmc.com/irhythm-technologies-inc-securities-class-action?utm_source=PR&utm_medium=link&utm_campaign=irhythm Contact:James Maro, Esq. (484) 270-1453 Adrienne Bell, Esq. (484) 270-1435 Toll free (844) 887-9500 According to the complaint, iRhythm is a digital healthcare company that offers a portfolio of ambulatory cardiac monitoring services on its platform called the Zio service. iRhythm receives revenue for its Zio service primarily from third-party payors, which includes commercial payors and government agencies, such as the U.S. Centers for Medicare and Medicaid Services (“CMS”). On August 3, 2020, the CMS issued its Calendar Year 2021 Medicare Physician Fee Schedule Proposed Rule, which would update payment policies, payment rates, and other provisions for services to be furnished under the Medicare Physician Fee Schedule on or after January 1, 2021. Kevin M. King, then President and CEO of iRhythm, praised the impact the proposed rule would have on iRhythm’s business and revenues. However, the truth began to be revealed on December 1, 2020, when the CMS issued its final rule, which finalized the codes as anticipated, but did not finalize national pricing for certain products and services offered by iRhythm. On December 2, 2020, iRhythm’s common stock opened at $183.00 per share, down from the December 1, 2020 close of $240.64. Then on January 29, 2021, Medicare Administrative Contractor, Novitas Solutions, published actual reimbursement rates under the CMS’s 2021 Medicare Physician Fee Schedule. A Baird analyst commented that these rates were “way lower than” the former codes, citing one example where iRhythm was previously reimbursed around $311, but was now receiving just $42.68. Following this news, the price of iRhythm’s common stock closed at $168.42 on January 29, 2021, down approximately 33% from its January 28, 2021 close of $251.00. iRhythm investors may, no later than April 2, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP, or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com. CONTACT: Kessler Topaz Meltzer & Check, LLPJames Maro, Jr., Esq.Adrienne Bell, Esq.280 King of Prussia RoadRadnor, PA 19087(844) 887-9500 (toll free)(610) 667-7706info@ktmc.com